Traws Pharma (TRAW) Current Taxes (2013 - 2014)
Traws Pharma (TRAW) posted quarterly Current Taxes of $18000.0 for Q4 2014, down 94.04% year-over-year from $302000.0 in Q4 2013, and down 10.0% quarter-over-quarter from $20000.0 in Q2 2014.
Traws Pharma (TRAW) Current Taxes (2013 - 2014) Analysis & Trends
Traws Pharma (TRAW) has reported Current Taxes for 2 consecutive years, with $18000.0 the latest figure, recorded in Q4 2014.
- In Q4 2014, Current Taxes fell 94.04% year-over-year to $18000.0; the TTM figure through Dec 2014 stood at $18000.0 (down 94.04% YoY), while the FY2014 annual figure was $18000.0, down 94.04% from the prior year.
- Current Taxes retreated to $18000.0 in Q4 2014 per TRAW's latest filing, from $20000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $432000.0 in Q3 2013 and bottomed at $18000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.36 Mn |
| 10 | Traws Pharma | 5.60 Mn | 588,417.40 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 18,000.00 |
| Jun 30, 2014 | 20,000.00 |
| Mar 31, 2014 | 208,000.00 |
| Dec 31, 2013 | 302,000.00 |
| Sep 30, 2013 | 432,000.00 |